Sept. 12, 2025:
The Big Ten Cancer Research Consortium (Big Ten CRC) congratulates Greg Durm, MD, on receiving the 2025 Pat Loehrer Award for Exemplary Collaboration in Cancer Research.
- Home
- About Us
- News & Events
- Leadership
- Raymond J. Hohl, MD, PhD
- Raphael E. Pollock, MD, PhD
- Monika Joshi, MD, MRCP
- Oana Danciu, MD
- Timothy Fan, PhD, DVM
- Nabil Adra, MD
- Muhammad Furqan, MD
- Vu Hong Duong, MD, MS
- Aki Morikawa, MD, PhD
- Daniel Isaac, DO
- Veronika Bachanova, MD, PhD
- Vijaya Raj Bhatt, MBBS, MS
- Jyoti Patel, MD
- John L. Hays, MD, PhD
- Patrick C. Ma, MD, MSc
- Thomas G. Sors, PhD
- Salma Jabbour, MD
- Kari Wisinski, MD
- Member Institutions
- University of Illinois Cancer Center
- The Cancer Center at Illinois
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Holden Comprehensive Cancer Center, University of Iowa
- The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- University of Michigan Rogel Cancer Center
- Michigan State University Cancer Research
- Masonic Cancer Center, University of Minnesota
- Fred & Pamela Buffett Cancer Center (University of Nebraska)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Penn State Cancer Institute
- Purdue University Institute for Cancer Research
- Rutgers Cancer Institute
- Fred Hutch Cancer Center
- University of Wisconsin Carbone Cancer Center
- Clinical Research
- Current Trials
- Research Criteria
- Health Equity Resources
- Adolescent and Young Adult Clinical Trial Working Group
- Basket Trial Clinical Trial Working Group
- Bone Marrow / Stem Cell Transplant Clinical Trial Working Group
- Breast Cancer Clinical Trial Working Group
- Comparative Oncology Working Group
- Correlative Sciences Clinical Trial Working Group
- Gastrointestinal Clinical Trial Working Group
- Genitourinary Clinical Trial Working Group
- Gynecologic Clinical Trial Working Group
- Head and Neck Clinical Trial Working Group
- Lymphoid Malignancies Clinical Trial Working Group
- Melanoma/Cutaneous Oncology Clinical Trial Working Group
- Multiple Myeloma Clinical Trial Working Group
- Myeloid Malignancies Clinical Trial Working Group
- Neuro-Oncology Clinical Trial Working Group
- Population Science Working Group
- Sarcoma Clinical Trial Working Group
- Thoracic Clinical Trial Working Group
- Donate
- Contact
News & Developments
Big Ten CRC honors Bailey with 2025 Distinguished Leadership Award
Sept. 12, 2025: The Big Ten Cancer Research Consortium honored Howard Bailey, MD, with the 2025 Distinguished Leadership Award today during its annual Summit at Big Ten Conference Headquarters in Rosemont, Ill. Read More
Global Oncology Symposium 2025
Sept. 3, 2025 The Big Ten Cancer Research Consortium and the University of Wisconsin–Madison are pleased to announce the 2025 Global Oncology Symposium on December 10, 2025. This annual event brings together clinicians, researchers, advocates, and thought leaders from around the world to advance the conversation on global cancer research and care. Read More
Don’t Miss Chris Draft, advocate and Former NFL Linebacker, at the Big Ten CRC Summit – Register Now
Sept. 1, 2025
The Big Ten Cancer Research Consortium Summit returns on Friday, September 12, 2025, bringing together investigators and research leaders from Big Ten CRC institutions, industry partners, and research advocates, for a day full of collaboration, idea exchange, and scientific momentum.
Set at the Big Ten Conference Headquarters in Rosemont, Ill., the annual summit continues its tradition of fostering institutional connections and accelerating progress in cancer research. This year’s program combines networking opportunities with scientific updates and discussions on relevant topics impacting research institutions across the United States. Chris Draft, former NFL linebacker and nationally recognized health advocate, will serve as the Summit’s special speaker, bringing a powerful...
Across the Consortium: August 2025
August 28, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights advances from our member institutions. From featuring groundbreaking research to innovative treatments and patient-centered care, these stories showcase the breadth of discovery driving progress across the Big Ten. Read More
Ma and Weiss Team Up as Co-Chairs of Melanoma Clinical Trial Working Group
July 28, 2025: Sarah Weiss, MD, of Rutgers Cancer Institute, joins Vincent Ma, MD, of the University of Wisconsin School of Medicine and Public Health, as co-chairs of the Big Ten Cancer Research Consortium’s Melanoma Clinical Trial Working Group. Read More
Member Feature: Fred Hutch Cancer Center
July 28, 2025: This month, the Big Ten Cancer Research Consortium highlights our member institution Fred Hutch Cancer Center and Lawrence (Larry) Fong, MD, who serves as scientific director of the Immunotherapy Integrated Research Center at Fred Hutch. Read More
Across the Consortium: July 2025
July 15, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights examples of discovery and impact from our member institutions. From grant-funded studies and groundbreaking therapies to new cancer center openings and community health outreach, this issue reflects the variety and depth of work advancing cancer research across the Big Ten. Read More
BTCRC-BRE18-337 journal article published in Breast Cancer Research and Treatment
July 15, 2025: A Big Ten CRC study, BTCRC-BRE18-337, led by Sneha Phadke, DO, MPH, of the University of Iowa Holden Comprehensive Cancer Center, was published in Breast Cancer Research and Treatment on June 5, 2025. The article is titled, “Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers.” Read More
BTCRC-BRE19-409 presented at AACR Annual Meeting 2025
April 25, 2025: A Big Ten CRC clinical trial, BTCRC-BRE19-409, titled, “Alpelisib (BYL719) with continued endocrine therapy following progression on endocrine therapy in hormone receptor–positive, HER2-negative, PIK3CA-mutant metastatic breast cancer,” was presented as a poster presentation at the American Association for Cancer Research® (AACR) Annual Meeting 2025 by Darian Louthan, clinical research coordinator at UW Carbone Cancer Center. Read More
Categories
Illinois
University of Illinois
Indiana
Indiana University
Iowa
University of Iowa
Maryland
University of Maryland
Michigan
University of Michigan
Michigan State
Michigan State
Minnesota
University of Minnesota
Nebraska
University of Nebraska
Northwestern
Northwestern University
Ohio State
Penn State
Penn State University
Purdue
Purdue University
Rutgers
Rutgers State University
Washington
University of Washington
Wisconsin
University of Wisconsin
UIC
University of Illinois at Chicago
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube